HemoglobinPub Date : 2025-07-01Epub Date: 2025-06-03DOI: 10.1080/03630269.2025.2514134
Weijie Xie, Cheng Lin, Yueying Huang, Ziling Yang, Houlong Luo, Rong He, Xiaohui Huang, Anping Xu, Ling Ji
{"title":"A Hemoglobin Variant, Resulting from a Novel Missense Mutation [CD 112(G14) Cys > Ser (TGT > TCT); <i>HBB</i>: C.338G > C], Was Discovered by MALDI-TOF MS.","authors":"Weijie Xie, Cheng Lin, Yueying Huang, Ziling Yang, Houlong Luo, Rong He, Xiaohui Huang, Anping Xu, Ling Ji","doi":"10.1080/03630269.2025.2514134","DOIUrl":"10.1080/03630269.2025.2514134","url":null,"abstract":"<p><p>Here we report a hemoglobin (Hb) variant, initially detected by matrix-assisted laser desorption ionisation-time of flight mass spectrometry (MALDI-TOF MS). A 29-year-old woman who presented to our hospital for a medical examination showed a remarkable discrepancy between her fasting plasma glucose level (5.07 mmol/L) and her HbA<sub>1c</sub> value (3.61%), as determined by capillary electrophoresis (CE). Hemoglobin analysis by MALDI TOF MS revealed an abnormal globin with a mass of 15853 Da. Sanger sequencing identified a novel missense mutation in exon 112 of the β-globin chain [CD 112(G14) Cys > Ser (TGT > TCT); <i>HBB</i>:c.338G > C]. In reference to the birthplace of the proband, this variant was named Hb Jiangxi.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"294-297"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144215688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2025-07-01Epub Date: 2025-06-08DOI: 10.1080/03630269.2025.2514801
Maria Oggionni, Barbara Manenti
{"title":"Hereditary Persistence of Fetal Hemoglobin (HPFH): Detection of Unknow <sup>A</sup>γ-Globin Promoter Mutation at the C2H2 Zinc Finger Transcription Factors Binding Sites.","authors":"Maria Oggionni, Barbara Manenti","doi":"10.1080/03630269.2025.2514801","DOIUrl":"10.1080/03630269.2025.2514801","url":null,"abstract":"<p><p>A 31-year-old pregnant African woman presents to our unit following hemoglobin-HPLC analysis, which reveals a slightly elevated HbF fraction (4.2%). Molecular analysis of the α and β-globin genes did not detect any mutations. To further investigate her persistent fetal hemoglobin (HPFH), we performed Sanger sequencing of the γ-globin promoter. This analysis uncovered two unknow point mutations: <i>HBG1</i>: c.-305 A > G and <i>HBG2</i>: c.-309 A > G. Notably, the mutation in the <sup>A</sup>γ-globin promoter lies within the AGGAA binding site of the C2H2 zinc finger transcription factor IZKF1. This mutation may account for the patient's HPFH and highlights the importance of analyzing all promoter binding sites in genome editing-based therapies for β-thalassemia.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"298-300"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144247651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2025-07-01Epub Date: 2025-06-10DOI: 10.1080/03630269.2025.2490291
Ping Liu, Jieyu Wang, Hongyu Luo, Xue-Wei Tang, Jianying Zhou, Fan Jiang, Jin Han
{"title":"A Novel Large Deletion Including the Major Regulatory Element Compounded with SEA Deletion Causing Hydrops-Fetalis-Syndrome.","authors":"Ping Liu, Jieyu Wang, Hongyu Luo, Xue-Wei Tang, Jianying Zhou, Fan Jiang, Jin Han","doi":"10.1080/03630269.2025.2490291","DOIUrl":"10.1080/03630269.2025.2490291","url":null,"abstract":"<p><p>MCS-R regulatory elements are very important for the synthesis of α-globin. Deletion of the major α-globin regulatory elements compounded with deletion of α-globin genes can cause Hb Bart's (c4) hydrops fetalis, which is the severe form of α-thalassemia. In this report, a 19-year-old female at the 16th week of gestation came to our center due to abnormal fetal cardiothoracic ratio and thickened placental depth. The electrophoresis result of fetal umbilical cord blood revealed the level of Hb Bart's band to be 87.6%, which suggested the fetus was Hb Bart's hydrops fetalis. Next generation sequencing screen using targeted capture was used to detect the genotype of the fetus to be -SEA deletion, βA/βA. Multiplex ligation-dependent probe amplification (MLPA) is very useful to detect copy number variation (deletions/duplications), the result of which suggested the existence of -SEA deletion compounded with the novel large deletion of the major α-globin regulatory element (MCS-R2, R1, R3 and R4). Using the self-designed MLPA probe, the deletion should extend from the telomere downstream and the downstream breakpoint was between 143702 and 144291(GRch38/hg18). The novel deletion was also observed in the fetus' father and grandfather who had mild anemia. Of cases with the MCS deletion compounded with α<sup>0</sup>-thalassemia, this was the earliest time when the fetus presented fetal edema. Our study gave more evidence for genetic counseling for MCS deletion.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"289-293"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2025-07-01Epub Date: 2025-08-04DOI: 10.1080/03630269.2025.2533229
Mohammad Ali Amini, Ali Afgar, Somayye Daneshi Cohan, Saeid Soleimani, Hajar Mardani Valandani, Alireza Farsinejad, Ali Bazi, Mahmood Khosravi, Roohollah Mirzaee Khalilabadi
{"title":"Association of Micro RNA-155 with Alloimmunization in Transfusion-Dependent Thalassemia Patients.","authors":"Mohammad Ali Amini, Ali Afgar, Somayye Daneshi Cohan, Saeid Soleimani, Hajar Mardani Valandani, Alireza Farsinejad, Ali Bazi, Mahmood Khosravi, Roohollah Mirzaee Khalilabadi","doi":"10.1080/03630269.2025.2533229","DOIUrl":"10.1080/03630269.2025.2533229","url":null,"abstract":"<p><p>Thalassemia is one of the most prevalent genetic disorders. Blood transfusion, as the main treatment, harbors diverse side effects, including alloimmunization to RBC antigens, exacerbating hemolysis, and blood requirements. The role of miR155, as a regulator of the immune system, was investigated to divulge its role in the production of alloantibodies in thalassemia patients. The antibody screening technique was used to identify TDT patients with alloimmunization against erythrocyte antigens. PBMC were isolated from selected TDT patients and matched controls using the Ficoll-Paque method, and then miRNA was extracted from cells by the TRIzol reagent. Finally, the relative expression of miR155 was measured using the stem-loop RT-PCR technique. One hundred fifty-eight patients with TDT were screened for the presence of alloantibodies, of whom 14 patients were identified to develop alloimmunization against RBC antigens. There was no statistically significant difference between TDT patients with or without alloantibodies (15 age and sex matched non-immunized patients) in terms of the frequencies of splenectomy, vaccination against hepatitis B, blood types, RHD positivity, and various complications. The expression of miR155 was significantly higher in patients with alloantibodies (mean fold change: 4.74 ± 2.76) compared to non-immunized TDT patients (mean fold change: 1.8 ± 0.68, <i>P</i> = 0.002). Our findings indicated that miR155 overexpression can be involved in modulating immune responses and triggering the production of alloantibodies in TDT patients. More studies are required in this field to further elucidate the role of miR155 in alloimmunization of these patients and other conditions associated with this problem.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"268-274"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144784189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Heterozygous Beta Thalassemia with Segmental Duplication of chr16p13.3 Leading to Thalassemia Intermedia Phenotype: A Report of 2 Cases with Review of Literature.","authors":"Ekta Jajodia, Neeraj Arora, Moquitul Haque, Tusti Ganguly, Mukesh Kumar, Spandan Chaudhary, Firoz Ahmad, Pooja Chaudhary, Ankit Jitani","doi":"10.1080/03630269.2025.2492696","DOIUrl":"10.1080/03630269.2025.2492696","url":null,"abstract":"<p><p>Heterozygous β-thalassemia is typically asymptomatic, but when accompanied by α-globin gene multiplication, patients may exhibit clinical symptoms. We present two rare cases of heterozygous β-thalassemia where segmental duplications on chr16p13.3 led to increased α-globin gene copies, resulting in a thalassemia intermedia phenotype. One patient exhibited a novel de-novo duplication spanning 2.57 MB, while the other had a 173.8 KB duplication at the chr16p13.3 locus. These two cases are presented to underscore the significance of thorough and systematic evaluation in diagnosing rare forms of thalassemia accurately. Our study also compiles all reported cases of heterozygous β-thalassemia with large segmental duplications on chr16p13.3, leading to an excess of α-globin genes. A total of ten studies have been published in the literature so far. Importantly, the 2.57 MB segmental duplication identified in our study is a novel variant not previously documented in the literature.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"222-228"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144017191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hepatobiliary Manifestations in Thalassemia Patients: A Narrative Review.","authors":"Asha Tiwari, Ekta Rao, Iswarya Suresh, Manish Tiwari, Ravindra Kumar","doi":"10.1080/03630269.2025.2493946","DOIUrl":"10.1080/03630269.2025.2493946","url":null,"abstract":"<p><p>Thalassemia is one of the most common inherited blood disorders worldwide. This defect causes a disproportionate ratio of α- and β-globin chains resulting in ineffective erythropoiesis leading to increased iron absorption. In patients where the imbalance between α and β globin chains is great they are dependent on blood transfusions for survival. This results in transfusional iron overload but also comes with additional risks such as transfusion-transmissible viral infections like hepatitis B and C. This can lead to various complications like liver fibrosis, cirrhosis and hepatocellular carcinoma, which are important causes with morbidity and mortality in patients of thalassemia today. These hepatobiliary manifestations and their management are briefly discussed in this review. Understanding hepatobiliary complications in thalassemia is vital for optimizing patient care.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"200-207"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144012118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2025-05-01Epub Date: 2025-05-29DOI: 10.1080/03630269.2025.2509004
Ida Stangerup, Andreas Glenthøj, Nanna Brøns, Majbritt Lund Witte, Ole Birger Pedersen, Christian Erikstrup, Jesper Petersen, Sisse Rye Ostrowski, Thore Hillig
{"title":"High Prevalence of Hb Riccarton Challenges HbA1c Analysis in a Danish Clinical Laboratory Using the Tosoh G11.","authors":"Ida Stangerup, Andreas Glenthøj, Nanna Brøns, Majbritt Lund Witte, Ole Birger Pedersen, Christian Erikstrup, Jesper Petersen, Sisse Rye Ostrowski, Thore Hillig","doi":"10.1080/03630269.2025.2509004","DOIUrl":"10.1080/03630269.2025.2509004","url":null,"abstract":"<p><p>Ion-exchange high-performance liquid chromatography (HPLC) is commonly used to measure hemoglobin A1c (HbA1c) by distinguishing it from other hemoglobin (Hb) fractions based on net charge. Hb variants can interfere with this analysis, leading to spurious HbA1c results, particularly in HPLC-based methods. This study investigated blood samples showing an HV3 peak - which indicates an Hb variant - on the Tosoh G11 chromatogram during routine HbA1c analysis in a Danish laboratory. Over 30 workdays, 53/33,006 samples displayed an HV3 peak. Sanger sequencing identified Hb Riccarton as the most common variant associated with these peaks (n = 27), consistent with its prevalence in the Danish Blood Donor Study, suggesting it is common in the Danish Caucasian population. Hb Riccarton posed a particular analytical challenge, as over half of the cases showed fluctuating HV3 peaks, initially separated from the HbA1c fraction but subsequently integrated into it upon re-analysis. In regions where Hb Riccarton is prevalent, clinical laboratories using the Tosoh G11 must be aware of this phenomenon to avoid bias and inconsistency in HbA1c reporting. Following Hb Riccarton, HV3 peaks most often indicated HbE heterozygosity (n = 16). Compared to Tosoh G11, HbA1c from the DCA Vantage showed a mean bias of -9.7% for HbE, versus -2.1% in samples without Hb variants. For Hb Riccarton, the bias was -7.2% when the HV3-peak was integrated, and +8.6% when separated from the HbA1c fraction. However, if clinicians are aware of these variants being present, both methods may be used for diabetes monitoring if applied consistently.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"187-194"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2025-05-01Epub Date: 2025-04-14DOI: 10.1080/03630269.2025.2489634
Zachary Ramsay, Deva Sharma, Margaret Wisdom-Phipps, Nicki Chin, Leroy Campbell, Jennifer Knight-Madden, Monika Asnani
{"title":"Estradiol is Pro-Nociceptive and Associated with a Small-Fiber Neuropathy Among Premenopausal Women with Sickle Cell Disease.","authors":"Zachary Ramsay, Deva Sharma, Margaret Wisdom-Phipps, Nicki Chin, Leroy Campbell, Jennifer Knight-Madden, Monika Asnani","doi":"10.1080/03630269.2025.2489634","DOIUrl":"10.1080/03630269.2025.2489634","url":null,"abstract":"<p><p>Vaso-occlusive crisis (VOC) pain episodes often occur with menses and concurrent hormonal contraceptive use may reduce their frequency. This study tested the hypothesis that among women with sickle cell disease (SCD), sex hormones are associated with pain detection thresholds. Women with SCD aged minimum 18 years with regular menses, and without acute illnesses, pregnancy, oophorectomy, or hormonal contraceptive use within three months prior were included. Pain detection thresholds for heat (HPT) and pressure (PPT), and serum estradiol, progesterone and testosterone were measured at follicular and luteal phases. The Adult Sickle Cell Quality-of-Life Measurement Information System assessed quality-of-life and VOC frequency and severity scores. Generalized linear mixed models were performed, including the day of the cycle standardized by cycle length. Among 125 participants, neither the day nor phase of the menstrual cycle was associated with PPT or HPT. In multivariate analyses, worse VOC scores (<i>β</i> = 1.7) and severe genotype (<i>β</i> = -46.0) were associated with higher and lower trapezius PPT, respectively. Older age was associated with lower forearm HPT (<i>β</i> = -0.1). Among leg measurements, ovulatory cycles (<i>β</i> = -1.1) and hydroxyurea use (<i>β</i> = -1.2) were associated with lower HPT, while worse VOC scores (<i>β</i> = 0.1) were associated with higher HPT. Higher estradiol was associated with lower HPT at the leg (<i>β</i> = -0.02), with an interaction with the cycle day (<i>β</i> = 0.001) predicting lower thresholds earlier in the cycle for the same estradiol level. Estradiol is associated with a time-varying, length-dependent small-fiber neuropathy among SCD women; and may be a potential therapeutic target and biomarker for SCD pain.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"161-171"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143965537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Characterization of HbH Disease Caused by Compound Heterozygotes α<sup>+</sup>-Thalassemia 3.7 kb Deletion and a Large Novel α<sup>0</sup>-Thalassemia Deletion.","authors":"Chedtapak Ruengdit, Manoo Punyamung, Kritsanee Maneewong, Pinyaphat Khamphikham, Wanicha Tepakhan, Sakorn Pornprasert","doi":"10.1080/03630269.2025.2495698","DOIUrl":"10.1080/03630269.2025.2495698","url":null,"abstract":"<p><p>We characterized here for the first time the deletional HbH disease caused by a large novel α<sup>0</sup>-thalassemia deletion in a 26-year-old Burmese pregnant woman. Capillary electrophoresis (CE) electropherogram revealed HbA<sub>2</sub>ABart's H, whereas, a single-tube multiplex real-time PCR with EvaGreen and high-resolution melting (HRM) analysis for diagnosis of three common α<sup>0</sup>-thalassemia --<sup>SEA</sup>, --<sup>THAI</sup>, and --<sup>CR</sup> deletions showed a negative result. Thus, a multiplex ligation-dependent probe amplification (MLPA) analysis was performed. The α-globin gene cluster deletion was observed spanning from upstream of <i>HBZ</i> to downstream of HBQ1 exon 3 covering three functional genes (<i>HBZ</i>, <i>HBA2</i>, and <i>HBA1</i>). This large novel deletion has not been reported previously thus we named it α<sup>0</sup>-thalassemia (--<sup>BURMESE</sup>) due to its origin. In addition, deletional HbH disease is a result of compound heterozygosity for --<sup>BURMESE</sup>/-α<sup>3.7</sup>. Therefore, the characterization and identification of --<sup>BURMESE</sup> is essential for genetic counseling and preventing new cases of HbH disease and Hb Bart's hydrops fetalis.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"229-232"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144008315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2025-05-01Epub Date: 2025-05-14DOI: 10.1080/03630269.2025.2489639
Selma Kofoed Bendtsen, Richard van Wijk, Jesper Brix Petersen, Per Jensen, Jens Helby, Andreas Glenthøj
{"title":"Rare Case of Homozygosity for CYB5R3 Variant c.235C > T p.(Arg79Trp) Causing Type II Methemoglobinemia.","authors":"Selma Kofoed Bendtsen, Richard van Wijk, Jesper Brix Petersen, Per Jensen, Jens Helby, Andreas Glenthøj","doi":"10.1080/03630269.2025.2489639","DOIUrl":"10.1080/03630269.2025.2489639","url":null,"abstract":"<p><p>Type II methemoglobinemia is a rare genetic condition in which deficiency of the enzyme NADH-cytochrome b5 reductase 3 encoded by the gene <i>CYB5R3</i> causes neurological symptoms in addition to elevated blood methemoglobin levels. The clinical presentation of Type II methemoglobinemia extends beyond hematological symptoms and include developmental delays, intellectual disability, and severe neurological symptoms. Here we present a case of a young male of Turkish origin diagnosed with type II hereditary methemoglobinemia at age 28. The proband has congenital hearing loss and was diagnosed with infantile autism in adolescence. After several hospital admissions with dyspnea, low oxygen saturation, methemoglobin levels at 4-19%, and normal p50 of 27.0 mmHg, he was evaluated for congenital methemoglobinemia. Genetic testing using targeted next generation sequencing identified the rare pathogenic <i>CYB5R3</i> c.235C > T p.(Arg79Trp) missense variant (NM_001171660.2, NP_001165131.1). Enzymatic testing of NADH-cytochrome b5 reductase 3 of the patient and the mother showed decreased activities of 0.6 U/g Hb and 6.7 U/g Hb, respectively, compared to a normal group with a mean of 12 U/g Hb (standard deviation 1.7 U/g Hb). The patient had hemoglobin levels within normal and osmotic gradient ektacytometry was performed and found normal. To our knowledge, this constitutes the first report of a <i>CYB5R3</i> c.235C > T homozygous. This case report emphasizes the importance of considering rare genetic disorders in patients with unexplained neurological and auditory deficits. The patient consented to publication of this case story.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"218-221"},"PeriodicalIF":1.2,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144005912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}